Skip to main content
. Author manuscript; available in PMC: 2017 Nov 30.
Published in final edited form as: NPJ Precis Oncol. 2017 Jun 12;1:20. doi: 10.1038/s41698-017-0020-3

Fig. 1.

Fig. 1

Longitudinal imaging in GBM patients treated with cediranib in combination with standard chemoradiation. Metabolic, perfusion, and anatomical MR images are shown from a patient with short OS (left) and long OS (right). The short OS patient is representative for PdR with rapid decrease of ce-T1; however, tCho/hCr and tCho/NAA remain elevated. In long OS patient, the decrease of ce-T1 is accompanied by decrease of tCho/hCr and tCho/NAA. Spectra from a region inside tumor are shown on the upper row. The red rectangle overlaid on ce-T1 images indicates the VOI covered by the MRSI acquisition